NCT04381130

A Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2027-04-01Est. Completion: 2029-12-31

Enrollment target: 30 participants

Contact

David Liu, PhDcoldwee@efbiotech.com +88638630108

Other microbiome trials you might be interested in

Breath Research Narrow Validation for Gastrointestinal Cancer DetectionRecruiting

Oesophageal Squamous Cell CarcinomaOesophageal AdenocarcinomaGastric AdenocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)CholangiocarcinomaHepatocellular Carcinoma (HCC)Colorectal Adenocarcinoma

The investigators of this study are developing a simple breath test to help detect gastrointestinal (gut) cancers earlie…

Maidstone, United KingdomEst. completion Feb 2, 2028

View Trial →

SwissNET - a Registry for Neuroendocrine Tumours in SwitzerlandTERMINATED

Neuroendocrine TumorsCarcinoid Tumor

Gastroentero-pancreatic neuroendocrine tumours (GEP-NETs) are regarded as a fairly rare disease. They are derived from t…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.